Details for New Drug Application (NDA): 215519
✉ Email this page to a colleague
The generic ingredient in VIGABATRIN is vigabatrin. There are five drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the vigabatrin profile page.
Summary for 215519
Tradename: | VIGABATRIN |
Applicant: | Propel Pharma |
Ingredient: | vigabatrin |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 215519
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 500MG | ||||
Approval Date: | Apr 28, 2023 | TE: | AB | RLD: | No |
Complete Access Available with Subscription